Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New funding supports Affinivax's development of novel pneumococcal vaccine

Feb. 9, 2016

Microbix Biosystems to develop products to combat Zika virus

Feb. 8, 2016

Zepatier approved in Canada for the treatment of chronic HCV genotypes 1, 3 or 4

Feb. 8, 2016

Bavarian Nordic collaborates with Evaxion Biotech and DTU to develop a novel MRSA vaccine

Feb. 8, 2016

U.K. Medical Research Council launches Zika virus research initiatives

Feb. 5, 2016

Bharat Biotech announces Zika virus vaccine program

Feb. 5, 2016

Enyo secures funding to support hepatitis B program

Feb. 5, 2016

GeoVax Labs announces its plans to develop Zika virus vaccine

Feb. 4, 2016

Companies investigate approaches to tackle Zika virus

Feb. 3, 2016

Matinas BioPharma cleared to initiate phase I clinical study of MAT-2501

Feb. 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...